Givaudan SA (OTCMKTS:GVDNY – Get Free Report)’s stock price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $71.06 and traded as high as $72.87. Givaudan shares last traded at $71.96, with a volume of 25,368 shares.
Analyst Ratings Changes
A number of equities analysts recently commented on the stock. Kepler Capital Markets downgraded shares of Givaudan from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 13th. The Goldman Sachs Group lowered shares of Givaudan from a “strong-buy” rating to a “sell” rating in a report on Tuesday, February 10th. Barclays lowered shares of Givaudan from a “strong-buy” rating to a “hold” rating in a report on Friday, March 27th. Berenberg Bank lowered shares of Givaudan from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 31st. Finally, Zacks Research raised shares of Givaudan from a “strong sell” rating to a “hold” rating in a report on Monday, May 18th. Two research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.
View Our Latest Stock Analysis on Givaudan
Givaudan Stock Performance
About Givaudan
Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company’s core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.
Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.
Read More
- Five stocks we like better than Givaudan
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.
